Introduction
As a healthcare practitioner, I understand that semaglutide or tirzepatide may be too costly or hard to access for many people. Fortunately, there are effective alternatives. In this detailed, user-friendly overview, I’ll explain how these medications work, how you take them, what they cost, how well they work, and who they might help most — all using everyday language and clear definitions. I’ll also include clinical trial effectiveness and practical advice.
Let’s break down the six most common options in clear, easy-to-understand terms.
1. Phentermine
1.1 What is it and how it works
Phentermine is a pill taken by mouth. It’s called asympathomimetic amine, which means it acts like adrenaline in your body. By stimulating the central nervous system, phentermine increases heart rate and energy expenditure slightly. However, the primary weight-loss effect comes from appetite suppression, not a massive increase in metabolic rate. Instead, it increases levels of a chemical called norepinephrine in a part of the brain (the hypothalamus) that controls hunger. You feel less hungry and eat less as a result.
1.2 FDA Approval
Phentermine is FDA‑approved for up to 12 weeks for weight loss and should be used with diet and exercise. In real-world clinical practice, many healthcare providers prescribe it for longer durations, especially under careful monitoring. This is considered “off-label” use which means using a prescription medication for a purpose that is not officially approved by the FDA, but is still legal and often supported by clinical evidence or expert guidelines.
The original approval dates back to 1959, when long-term obesity trials weren’t common. The FDA label hasn’t been updated to reflect modern evidence or long-term outcomes. So, the 12-week limit is more about regulatory history than clinical evidence of harm after 12 weeks.
Despite its age, phentermine remains the most commonly prescribed anti-obesity medication in the U.S., often used alone or in combination with other drugs (like topiramate in Qsymia discussed later)
1.3 Dosing instructions / Titration Dose (Titration)
Usually 15–37.5 mg pill taken once a day in the morning.
While phentermine doesn’t have an official FDA-approved titration (dosing adjustment) schedule like some newer weight-loss medications, many clinicians use flexible titration strategies based on individual tolerance and response.
| Day(s) | Suggested Dose | Notes |
| Days 1–3 | 8 mg or half of 15 mg (once daily AM) | Start low if sensitive to stimulants; monitor for insomnia or jitteriness |
| Days 4–7 | 15 mg once daily (AM, 30 minutes before breakfast) | Standard starting dose for most adults |
| Week 2 onward | Increase to 30 mg if needed | For patients not experiencing appetite suppression at 15 mg |
| Optional full dose | 37.5 mg once daily (AM) | Max standard dose; only if previous doses are well tolerated |
| Alternative approach | Split 37.5 mg (½ AM, ½ mid-afternoon) | For better coverage of evening hunger or if full AM dose causes a crash |
1.4 Cost & Insurance Criteria
- Generic prices are around $30–$60 a month
- Insurance generally requires a body max index or BMI of 30 or higher—or BMI of 27 or more combined with conditions like type 2 diabetes or high blood pressure.
1.5 Weight Loss Results / Efficacy
- Expect about 3–5% weight loss in 12 weeks. Most weight is lost early, then often plateaus.
- Studies have shown that over 24 months you may still see additional weight loss, just not as quickly in the first 12 weeks.
Phentermine Effectiveness in Clinical Studies
| Study Type | Duration | Average Weight Loss | Notes |
| Randomized Placebo Trial1 | ~22 weeks | ~35.5 lbs (phentermine) vs. ~8.6 lbs(placebo) | Statistically significant difference |
Continuous vs Intermittent Use1 | ~36 weeks | ~26.9 lbs (continuous), ~28.6 lbs(intermittent), ~10.6 lbs (placebo) | Similar benefit with either dosing approach |
| Observational Cohort2 | 24 months | ~16.5 lbs more weight loss in long-term users vs short-term users | No cardiovascular risk increase observed |
1.6 Post-GLP1 Use Case
Phentermine is most helpful for:
- Patients who experienced strong hunger rebound after stopping semaglutide/tirzepatide
- Those needing a temporary bridge (1-3 months) while transitioning to another long-term med (e.g., Contrave – discussed later in this article).
- People with good response to phentermine in the past, who tolerate stimulants well.
1.7 Common Side Effects from Phentermine
Phentermine has been in use for decades and its side effects are well known and manageable for most people. Always work with your prescriber to help manage any potential side effects.
| Side Effect | Frequency | Why It Happens | Management Strategy |
| Dry Mouth | ~20–30% | Stimulation of nervous system reduces saliva production | Sip water frequently, chew sugar-free gum or lozenges |
| Insomnia | ~10–20% | Central nervous system stimulation interferes with sleep | Take dose early (before 10 AM); avoid caffeine; reduce dose |
| Increased Heart Rate | ~10–15% | Adrenergic stimulation increases sympathetic tone | Monitor pulse; lower dose if needed; avoid other stimulants |
| Restlessness / Jitteriness | ~10–15% | CNS activation overstimulates alertness pathways | Reduce dose; consider behavioral calming strategies |
| Dizziness | ~5–10% | Mild dehydration or blood pressure shifts | Hydrate well; stand up slowly; check vitals regularly |
| Headache | ~5–10% | Possibly from vasoconstriction or dehydration | Stay hydrated; consider over-the-counter pain relievers |
| Constipation | ~5–10% | Decreased bowel motility from sympathetic nervous system effects | Increase fiber and water intake; consider fiber supplements |
| Anxiety | ~5–10% | Stimulant-induced arousal or underlying predisposition | Avoid caffeine; use relaxation techniques; consider dose reduction |
| Elevated Blood Pressure | <10% | Mild vasoconstriction from stimulant effects | Monitor BP regularly; adjust dose or stop if BP stays elevated |
| Palpitations | <5–10% | Perception of increased heart rate or skipped beats | Monitor; usually self-limited; reduce dose or discontinue if persistent |
Best practice is to use a gradual titration schedule (starting on a low dose and increasing slowly) to help reduce side effects.
1.8 Limitations of Phentermine for Long-Term Maintenance
- Only approved by FDA for short-term use (up to 12 weeks), but often prescribed off label for longer term use when medically supervised. Clinical studies have shown low risk with long term use.
- Appetite suppression often fades over time (tolerance can develop)
- Not suitable for everyone: can worsen anxiety, sleep issues, or high blood pressure
- Doesn’t improve metabolic markers (blood sugar, cholesterol) like GLP-1s do
1.9 Who its best for / Ideal Candidates
People needing a short-term “kick start” or those who snack frequently and need appetite suppression.
It may help maintain weight loss after GLP‑1 tapering in the first few months, but its use is often limited to short-term, in part because it is a schedule IV controlled substance due to its stimulant nature and has potential for abuse.
Phentermine is inexpensive and widely available, making it a practical option or a short-term solution while transitioning to lifestyle or other longer-term meds like Contrave or Qsymia.
2. Phentermine/Topiramate (Qsymia®)
2.1 What is it and how it work
A single pill that combines phentermine (discussed above) with topiramate—an anticonvulsant typically used to treat seizures, which has also been found to promote weight loss and in 2012 the combination was FDA approved for obesity management. Together, they reduce appetite and make food taste less appealing.
2.2 Dosing instructions / Titration
Typical titration (dosing adjustment) starts very low and increases over weeks up to 15 mg phentermine / 92 mg topiramate daily — based on tolerance. Gradual titration allows you to increase the dosage till you see the desired effects while managing any potential side effects.
Phentermine/Topiramate Example Titration Schedule
| Titration Step | Dose (phentermine/topiramate) | Duration |
| Start | 3.75 mg / 23 mg | 2 weeks |
| Step 2 | 7.5 mg / 46 mg | Ongoing |
| Optional Step Up | 11.25 mg / 69 mg | 2 weeks (if needed) |
| Max Dose | 15 mg / 92 mg | Long-term |
2.3 Cost & Insurance Criteria
- Costs about $400–$600/month.
- The medication is brand-name only (Qsymia) and still on patent until 2028-2029 limiting more affordable generic options
- Insurance typically requires a body mass index (BMI) of 30 or greater
- May also be covered with BMI of 27 or more with at least one health condition. For example, Type 2 diabetes, High blood pressure, High cholesterol, Obstructive sleep apnea, or Fatty liver disease.
- Insurance often requires documentation of lifestyle failure, such as proof that non-medication approaches were tried and didn’t work.
2.4 Weight Loss Results / Efficacy
- Two well documented studies have shown participants lost on average 7–11% body weight over 56 weeks.
- Notably, about 70% of participants on top dose lost at least 5% body weight and 48% of people achieved greater than 10% weight loss.
| Study | Average % Weight Loss | Average Pounds Lost (220-lb person) | % Losing ≥5% Body Weight | % Losing ≥10% Body Weight | Study Duration |
EQUIP trials3 | ~10.9% | ~24 lbs | Not specified | 48% | 56 weeks |
CONQUER4 | ~9.8% | ~22 lbs | ~70% | ~48% | 56 weeks |
2.5 Post-GLP1 Use Case
While no large trials directly study GLP‑1 tapering with Phentermine/Topiramate, clinical experience supports it because:
- Drug combination has a strong appetite suppressing profile
- It supports long-term maintenance (over 1 year) in trials like CONQUER and EQUIP
- The dual mechanism (appetite + craving reduction) makes it an ideal maintenance therapy
2.6 Common Side Effects from Phentermine/Topiramate (Qsymia®)
Phentermine/Topiramate side effects have been well documented and are manageable for most people. Always work with your prescriber to help manage any potential side effects.
| Side Effect | Frequency | Why It Happens | Management Strategy |
| Paresthesia (tingling in hands/feet) | ~17–20% | Topiramate alters nerve signals, causing tingling sensations | Often mild; may resolve with time; stay hydrated and supplement with potassium or B12 |
| Dry mouth | ~19–21% | Stimulant effect reduces saliva production | Sip water regularly, chew sugar-free gum or lozenges |
| Constipation | ~17% | Topiramate can slow GI motility; decreased food intake also contributes | Increase fiber and water; use stool softeners or fiber supplements |
| Insomnia | ~10–15% | Phentermine stimulates the central nervous system | Take in the morning; avoid caffeine; consider reducing dose |
| Dizziness | ~9–11% | Mild dehydration or blood pressure changes | Stand slowly; stay hydrated; monitor BP |
| Dysgeusia (altered taste) | ~9–10% | Topiramate affects taste perception, especially for carbonated drinks | Avoid carbonated or strong-tasting foods; adjust food choices |
| Cognitive difficulties (“brain fog”) | ~7–10% | Topiramate may affect memory, attention, and word-finding | Use reminders, reduce distractions; dose reduction if persistent |
| Headache | ~7–10% | Changes in hydration or neurotransmitter activity | Stay hydrated; consider acetaminophen; monitor dose timing |
| Mood changes (e.g., anxiety, irritability) | ~5–9% | Both ingredients influence brain chemicals; individual sensitivity varies | Monitor mood closely; consider dose reduction or medication switch |
| Increased heart rate | ~5–10% | Phentermine stimulates sympathetic nervous system | Monitor HR regularly; avoid other stimulants; reduce dose if needed |
- Rare side effects include: depression or suicidal thoughts and kidney stones.
- Always use a gradual titration schedule (starting on a low dose and increasing slowly) to help reduce side effects.
2.7 Who its best for / Ideal Candidates
- Those who struggle with strong cravings or emotional eating,
- Individuals with difficulty sticking to diets
- People who need a higher-efficacy medication for moderate-to-severe obesity.
- Used to help prevent regaining weight after GLP‑1 use.
3.Naltrexone/Bupropion (Contrave®)
3.1 What it is and how it works
An oral tablet that combines the drugs naltrexone and bupropion into the medication known as Contrave which was FDA approved for weight management in 2014.
Naltrexone was originally FDA-approved for treating opioid addiction (1984) and alcohol dependence (1995) and is an opioid receptor antagonist, meaning it blocks the pleasure/reward receptors in the brain.
· By blocking the rewarding effect of food, naltrexone reduces cravings and compulsive eating.
· It disrupts the reinforcement loop, making it easier to resist emotional or binge-style eating.
Bupropion was FDA approved as an antidepressant (1985) and smoking cessation aid (1997) and boosts dopamine and norepinephrine, which:
· Suppress appetite
· Improves energy and motivationWhen paired, naltrexone enhances bupropion’s effect in the hypothalamus and mesolimbic reward system — two brain areas involved in hunger and food reward, and together, they synergistically reduce cravings and the rewarding feeling of food.
3.2 Dosing instructions / Titration
Often taken twice daily, with doses gradually increasing until reaching 32 mg naltrexone / 360 mg bupropion by week 4. Gradual titration allows you to increase the dosage till you see the desired results while managing any potential side effects.
Example Naltrexone/Bupropion (Contrave) Titration Schedule
| Week | Morning Dose | Evening Dose |
| Week 1 | 1 tablet | — |
| Week 2 | 1 tablet | 1 tablet |
| Week 3 | 2 tablets | 1 tablet |
| Week 4+ | 2 tablets | 2 tablets (full dose) |
3.3 Cost & Insurance Criteria
- Costs about $200–$450/month.
- Brand-only and expected to stay on patent until 2032 limiting cheaper generic options
- Insurance criteria:
- Body Mass index (BMI) of 30 or greater
- Or BMI 27 or greater with certain conditions—for example Type 2 diabetes, High blood pressure, High cholesterol, Obstructive sleep apnea, or Fatty liver disease
- Often requires a prior authorization code.
3.4 Weight Loss Results / Efficacy
- Users typically lose 5–8% of body weight in 16 weeks5.
- Those achieving greater than 5% weight loss at 16 weeks often reached ~12% weight loss at one year. · People taking CONTRAVE lost 2-4x more weight6 compared to those who used diet and exercise alone.
3.5 Post-GLP1 Use Case
- In a recent cohort study of patients7 already on GLP‑1 therapy, adding Contrave led to an additional 4–5% weight loss, even in those who hadn’t previously responded well to GLP‑1s alone.
- Contrave’s craving modulation may be especially helpful for behavioral maintenance once GLP‑1 therapy ends.
3.6 Common Side Effects from Naltrexone/Bupropion (Contrave®)
Naltrexone/Bupropion side effects have been well documented and are manageable for most people. Always work with your prescriber to help manage any potential side effects.
| Side Effect | Frequency | Why It Happens | Management Strategy |
| Nausea | ~32% | Bupropion and naltrexone stimulate the brain’s appetite and reward centers, which can irritate the stomach | Start with low dose and titrate slowly; take with food; anti-nausea meds if needed |
| Constipation | ~20–30% | Reduced GI motility from norepinephrine activity and central effects | Increase fiber, fluids, and physical activity; use stool softeners if needed |
| Headache | ~15–20% | CNS activation and vascular effects; dehydration may contribute | Stay hydrated; consider OTC pain relief (acetaminophen) |
| Dizziness | ~10–15% | Lowered blood pressure or changes in brain signaling | Stand up slowly; hydrate well; check blood pressure |
| Insomnia | ~10–15% | Bupropion increases brain alertness and energy | Avoid evening dosing; take final dose by early afternoon; minimize caffeine |
| Dry mouth | ~10–12% | Bupropion reduces saliva production through stimulation of the CNS | Hydrate, suck on sugar-free candies or lozenges |
| Vomiting | ~10–12% | GI irritation and brainstem nausea pathways triggered | Take with food; reduce fatty or heavy meals; antiemetics if persistent |
| Anxiety or irritability | ~8–12% | Bupropion increases norepinephrine and dopamine, which can overstimulate some users | Practice relaxation techniques; reduce dose; consider alternative medications |
| Sweating (hyperhidrosis) | ~7–10% | Bupropion increases central nervous system activity and metabolism | Wear breathable clothing; stay cool; report to provider if excessive |
- Rare side effects include: Increased blood pressure, suicidal thoughts, and seizures.
- Always use a gradual titration schedule (starting on a low dose and increasing slowly) to help reduce side effects.
3.7 Who Should Avoid Naltrexone/Bupropion (Contrave®)
- People taking opioids or with opioid dependence (due to risk of withdrawal)
- Anyone with a history of seizures or high seizure risk
- Individuals with uncontrolled hypertension
- Those under 25 years old with depression (due to suicidal ideation warning)
3.8 Who its best for / Ideal Candidates
- Individuals with strong cravings or emotional/reward-related eating,
- Those with mild depression symptoms.
- To help maintain weight loss after GLP‑1 use by reducing behavioral relapse.
4. Orlistat (Xenical® or OTC Alli®)
4.1 What is it and how it works
Orlistat is a pill taken orally that blocks fat absorption in the gut by ~30%. It’s not an appetite suppressant—rather, it prevents calories from being absorbed. It helps with modest weight loss and improves cholesterol, blood pressure, and insulin sensitivity in some users. It was FDA approved for long term weight management in 1999 and an OTC version was approved in 2007.
4.2 Dosing instructions / Titration
There are two versions of Orlistat,
- Name brand Xenical® which is available by prescription,
- Name brand Alli® which is available over the counter (OTC).
- The main difference is the dosage strength
- Generic versions of each option exist
– Both versions should be taken 3 times daily (with each meal) within 1 hour of eating.
– Orlistat only works if your meal has fat, and you can skip the dose if you are eating a fat free meal.
| Product Name | Dosage Strength | How to Take | Frequency |
| Xenical® (Prescription) | 120 mg | Take with each main meal that contains fat | 3 times daily |
| Alli® (OTC Version) | 60 mg | Also taken with each meal containing fat | 3 times daily |
4.3 Cost & Insurance Criteria
- Generic versions of Orlistat are available for between $20-$70 per month.
- The OTC brand name Alli® ~ $60/month;
- Prescription brand name Xenical® ~ $400/month.
- Insurance coverage varies; BMI criteria same as others.
4.4 Weight Loss Results / Efficacy
- Average weight loss of 7.6% with Orlistat8 versus ~2.0% with placebo at 24 months
- Over 2 years, 57% of Orlistat users maintained ≥5% weight loss9, versus 37.4% in placebo recipients
4.5 Post-GLP1 Use Case
Direct studies pairing Orlistat with GLP‑1 tapering are limited, but emerging real-world evidence and pharmacology suggest it can help maintain weight loss:
– In many patients who transitioned off GLP‑1 therapy, Orlistat aided in preventing weight regain by continuing fat-blocking effects despite reduced appetite suppression.
– Patients who lost significant weight on GLP‑1s may retain weight loss with Orlistat use combined with calorie-conscious eating, especially if fat intake remains low.
4.6 Benefits Beyond Weight Loss
- Reduces incidence of type 2 diabetes in high-risk patients.
- Improves blood pressure and LDL cholesterol modestly.
- Works locally in the gut — minimal systemic absorption and fewer hormonal side effects.
4.7 Common side effects from Orlistat (Xenical® or OTC Alli®)
Side effects from Orlistat are usually considered manageable and mostly affect the GI tract. They can be reduced through dietary changes.
| Side Effect | Frequency | Why It Happens | Management Strategy |
| Oily spotting | ~20–30% | Undigested fat passes into the stool due to blocked fat absorption | Reduce dietary fat to <15g per meal; wear dark clothing if needed |
| Urgent bowel movements | ~20–30% | Excess fat in stool can cause rectal urgency | Avoid high-fat meals; time meals and bathroom access |
| Flatulence with discharge | ~20–25% | Fermentation of undigested fat in the colon | Limit greasy/fatty foods; consider lower dose if persistent |
| Fatty or oily stools (steatorrhea) | ~20–30% | Inhibition of pancreatic lipase causes fat to remain undigested | Choose lean proteins; limit fried and fast food |
| Increased defecation | ~15–20% | Greater volume of unabsorbed food in gut | Normalize with dietary fiber; spread fat intake evenly |
| Abdominal pain/cramping | ~5–10% | Gas or bloating from malabsorbed fat | Reduce fat intake; consider probiotics or simethicone |
– Less common side effects include: Nausea, headaches, back pain, and mistrial irregularities.
4.8 Who its best for / Ideal Candidates
- Those motivated to adhere to low-fat diet
- Individuals who prefer to avoid stimulants or antidepressants.
- May be useful to maintain weight after GLP‑1 taper by continuing absorption-limiting effect.
5. Off‑Label Medications: Examples: Topiramate & Metformin
Off-label agents are medications that are prescribed for a use that is not officially approved by the FDA, but are still considered legal and medically acceptable in many cases.
– When a drug is FDA-approved, it’s approved for specific:
- Conditions (e.g., obesity, depression)
- Doses (mg, frequency)
- Patient populations (e.g., adults, children)
Off-label use means a licensed healthcare provider prescribes it outside those specific approvals.
– Often off label use is supported by clinical trials, real world evidence, and expert guidelines.
– A notable drawback to off-label use is that insurance companies usually require FDA approval for drug coverage, and people often pay for these medications out of pocket.
5.1 Topiramate (Topamax®)
5.1.1 What is it and how it works
Already discussed in depth in example combined with phentermine (brand name Qsymia®). Topiramate is also sold under the brand name Topamax® for the treatment of seizures and migraines.
Although Qsymia (phentermine + topiramate) is FDA approved for weight loss, taking just topiramate off label still has significant benefits and, having a generic option, is much more affordable, making it a strong candidate for both weight loss and as a maintenance drug to help keep the weight off after a GLP1 regimen.
5.1.2 Dosing instructions / Titration
- Off-label use at doses of 96–192 mg/day.
- Often dispensed as 100 mg tablets,
- Taken once or twice daily depending on regimen
- Start low and titrate slowly (e.g., 25 mg nightly, increase every 1–2 weeks)
5.1.3 Cost & Insurance Criteria
Low-dose or titration supply may cost as little as $5–$30/month.
– For mid/high doses (100–200 mg daily), retail cost ranges from $30–$150/month depending on pharmacy, dose, and discounts.
– Using discount programs like GoodRx or Cost Plus Drugs can reduce expenses to under $10/month in some cases — even for higher doses.
– Insurance usually doesn’t cover the cost of topiramate off label for use in weight loss
5.1.4 Weight Loss Results / Efficacy
– May lead to 4.8%–9.7% weight loss in 24–60 weeks when combined with diet and exercise.
– Studies have shown that topiramate can be nearly as effective for weight loss as phentermine combined with topiramate over a 1-year period
| Study | Dosage | Duration | Avg. Weight Loss | Notes |
| Gadde et al., 200310 | 96–192 mg/day | 24 weeks | 6.3–9.0% | Monotherapy (only topiramate) |
| Wilding et al., 200411 | 64–192 mg/day | 1 year | 5.0–9.7% | Monotherapy (only topiramate) |
| CONQUER4 trial (Qsymia) | 15/92 mg (combo) | 56 weeks | ~9.8% | Phentermine + Topiramate ER combo |
5.1.5 Effectiveness After GLP‑1 Therapy
While no large-scale clinical trials specifically examine topiramate for post-GLP-1 maintenance, indirect evidence is compelling:
- Studies have shown topiramate produces 5–10% weight loss as monotherapy, with less weight regain over time.
- Real-world clinical reports (especially from obesity specialists) frequently describe its use in transitioning off GLP-1s.
- A Kaiser Permanente study also noted phentermine/topiramate combo (Qsymia) users had durable weight loss over 2 years, suggesting utility in maintenance phases.
5.1.6 Common side effects of Topiramate
Topiramate side effects have been well documented and are manageable for most people. Always work with your prescriber to help manage any potential side effects.
| Side Effect | Frequency | Why It Happens | Management Strategy |
| Paresthesia (tingling) | ~30–40% | Alters nerve signaling in fingers/toes due to ion channel effects | Usually mild; stay hydrated; supplement potassium or B vitamins if needed |
| Cognitive impairment (“brain fog”) | ~15–25% | Affects neurotransmitters in brain; slows processing | Start low and titrate slowly; use reminders and minimize distractions |
| Drowsiness / fatigue | ~10–20% | CNS depressant effects | Take at bedtime; adjust dose if persistent |
| Dysgeusia (altered taste) | ~10–15% | Affects taste receptor signaling; especially reduces taste for sweet/carbonated foods | Avoid carbonated drinks; adjust diet as needed |
| Nausea | ~10–15% | GI irritation or CNS-related; worsened by quick titration | Take with food; titrate slowly; consider anti-nausea meds |
Less common side effects include: anxiety/depression, dizziness, kidney stones, Metabolic acidosis
5.1.7 Who its best for / Ideal Candidates
- Individuals with binge-eating tendencies or migraines who cannot tolerate phentermine.
- People looking for lower cost generic weight loss medications
- Patients who want help maintaining weight after GLP‑1 if cognitive effects tolerated.
5.2 Metformin
5.2.1 What is it and how it works
Metformin is a Diabetes drug with modest weight-loss effect often used in PCOS or insulin resistance.
- Metformin primarily acts in the liver, gut, and muscles to decrease hepatic glucose production, which Lowers insulin levels, reducing fat storage.
- It also improves metabolic efficiency and reduces appetite and decrease cravings.
- Metformin modestly slows gastric emptying, promotes early fullness, similar to low-level GLP-1 effects.
5.2.2 Dosing instructions / Titration
- Depending on the form of Metformin (Immediate-release or Extended-release) you take either with meals or once daily.
- Titration (dose increase): Increase every 7–14 days as tolerated to minimize GI side effects like nausea, diarrhea, and bloating.
Example Metformin Titration Schedule
| Form | Starting Dose | Typical Maintenance Dose | How to Take |
| Immediate-release (IR) | 500 mg once daily | 1000–2000 mg/day in divided doses | Take with meals to reduce GI upset |
| Extended-release (ER) | 500 mg once daily | 1000–2000 mg once daily | Preferred for better GI tolerance |
5.2.3 Cost & Insurance Criteria
- Generic metformin (500 mg tablets) — 60 tablets typically cost $10–$30/month depending on pharmacy and location.
- With GoodRx coupons, prices may be as low as $4–$6/month
- Extended-release (ER) versions (e.g., 750 mg or 1,000 mg) typically cost $4 to $29/month for a 30-day supply.
- Insurance usually doesn’t cover the cost of metformin off label for use in weight loss
5.2.4 Weight Loss / Efficacy
Metformin is modestly effective for weight loss, especially in people with insulin resistance. It is not a rapid weight-loss drug, but it is helpful for preserving losses, especially when combined with lifestyle interventions.
| Population | Average Weight Loss | Study Duration |
| Obese patients without diabetes | 4–6 lbs | ~6 months–1 year |
| Patients with PCOS | 5–10 lbs | ~6–12 months |
5.2.5 Effectiveness After GLP‑1 Therapy
Metformin is increasingly used by obesity specialists as a “maintenance bridge” after GLP-1 therapy:
Benefits:
- Reduces appetite rebound, helps blunt increase in hunger after GLP-1 stop
- Maintains insulin sensitivity, supports metabolic health and prevents weight regain
- Pairs well with other oral agents, for example, it can be combined with topiramate or orlistat
5.2.6 Common side effects of Metformin
Metformin has been used for decades and its side effects are well documented and manageable for most people. Always work with your prescriber to help manage any potential side effects.
| Side Effect | Frequency | Management Strategy |
| GI upset (nausea, diarrhea) | ~10–20% | Start low, take with food, use extended-release form |
| Metallic taste | ~5% | Usually transient |
| B12 deficiency | ~5–10% (long-term) | Check levels annually; supplement if low |
5.2.6 Who its best for / Ideal Candidates
Although Metformin is not FDA-approved for obesity or weight loss, it is widely used off-label in clinical practice, especially for:
· Individuals looking for a low risk, cheap, option to support weight maintenance post-GLP‑1 use
· Individuals with insulin resistance
· Women with PCOS-related weight issues
6. Summary: Keeping Weight Off After GLP‑1 Therapy
Many people regain weight when they stop GLP‑1 medications like semaglutide or tirzepatide. Transitioning to another maintenance medication can help.
- Phentermine might serve as a short-term bridge.
- Phentermine/Topiramate (Qsymia®) and Naltrexone/Bupropion (Contrave®) offer robust support for reducing hunger or cravings and may help sustain results.
- Orlistat may support maintenance if dietary fat remains low.
- Topiramate or metformin can be adjuncts for certain patients, depending on tolerance and comorbidities.
Comparison of Weight Loss Medications (Post-GLP1 and General Use).
| Medication | How It Works | Typical Dosing | Cost Estimate | Avg. Weight Loss | Effective After GLP1? | Ideal Candidates |
| Phentermine | Stimulant; increases norepinephrine to suppress appetite | 15–37.5 mg once daily (AM) | $30–$60/month (generic) | ~5% in 12 weeks; up to 16.5 lbs. over 24 months | Yes; useful short-term bridge | People needing a hunger suppressant, especially post-GLP1 rebound or early transition |
| Phentermine + Topiramate (Qsymia®) | Dual-action: appetite suppression and reduced food reward | Start at 3.75/23 mg; max 15/92 mg once daily | $400–$600/month (brand only) | 7–11% over 56 weeks | Yes; long-term efficacy and craving control | Moderate-to-severe obesity, emotional eating, strong rebound hunger |
| Naltrexone/ Bupropion (Contrave®) | Reduces cravings via reward system; boosts dopamine/ norepinephrine | 32 mg/360 mg/day (2 tabs BID) | $200–$450/month (brand only) | 5–8% in 16 weeks; up to ~12% in responders at 1 year | Yes; particularly in combo with GLP1 | Emotional/binge eaters, low mood, GLP1 non-responders needing craving control |
| Orlistat (Xenical® or Alli®) | Blocks ~30% of fat absorption in the gut | 60 mg (OTC) or 120 mg (Rx) to ingest with meals | $20–$70 (generic/ OTC); ~$400 Rx | ~7.6% over 24 months | Yes; prevents calorie regain without affecting appetite | Fat-conscious dieters, stimulant-avoidant, sensitive to central nervous system meds |
| Topiramate (Topamax®) off-label | Alters brain signals for hunger/satiety; reduces cravings and food reward | 25–100 mg/day (titrated slowly) | $5–$30/month (generic) | 5–9.7% in 24–60 weeks | Yes; evidence for use post-GLP1 taper | Binge eating, migraines, patients avoiding stimulants or on budget |
| Metformin (off-label) | Lowers insulin, slows gastric emptying, reduces cravings | 500–2000 mg/day (IR or ER) | $4–$30/month (generic) | 4–10 lbs in 6–12 months | Yes; helps prevent metabolic rebound | PCOS, insulin resistance, type 2 diabetes, post-GLP1 insulin sensitivity support |
No studies directly compare GLP‑1 taper with these alternatives, but clinical experience suggests they help reduce early regain.
7. Conclusion
These 6 medications offer a range of options beyond semaglutide or tirzepatide. Using clear dosing schedules, gradual titration, knowledge of side‑effect frequency and management, and matching treatment to a person’s eating behaviors or medical profile allows safer and more effective use. Transitioning thoughtfully from GLP‑1 therapy to another medication can help prevent weight regain—and when used as part of diet, exercise, and behavioral support, these alternatives remain valuable tools in long-term weight care.
Interested in Getting Started? Live in Connecticut?
If you’re interested in exploring one of these medications, or you’re looking for a way to prevent weight regain after stopping semaglutide or tirzepatide, I’d love to help.
Located in Connecticut?
We offer a free 15-minute consult to see if any of these medications might be a good fit for your weight management plan.
As a licensed Nurse Practitioner who specializes in weight loss and endocrinology, I can help guide you through safe options, answer your questions, and create a strategy tailored to your health goals.
8.Frequently Asked Questions (FAQs)
Absolutely. These medications are often used independently and are suitable for people who haven’t tried GLP-1 medications.
Yes, all of them—except OTC Orlistat (Alli®)—require a prescription and should be taken under medical supervision.
That’s very common. Several of these medications (like Qsymia®, Contrave®, or Topiramate) are used specifically to maintain weight loss and reduce hunger or cravings after GLP-1 therapy ends.
Most have long-term data. Qsymia® and Contrave® are FDA-approved for chronic weight management. Off-label options like Topiramate and Metformin are also widely used for long durations under supervision.
You’ll usually notice appetite suppression or reduced cravings within the first 1–2 weeks. Weight loss generally begins within 4–8 weeks, depending on the medication and your adherence.
In some cases, yes—but it depends on your health profile. For example, Metformin is often paired with Topiramate or Orlistat. Always consult a provider before combining medications.
Citations (clinical trials and studies)
1. Kim KK, Cho HJ, Kang HC, Youn BB, Lee KR. Effects on weight reduction and safety of short-term phentermine administration in Korean obese people. Yonsei Med J. 2006;47(5):614–625. doi:10.3349/ymj.2006.47.5.614. PMID: 17066505; PMCID: PMC2687747.
2. Lewis KH, Fischer H, Ard J, et al. Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. Obesity (Silver Spring). 2019;27(4):591–602. doi:10.1002/oby.22430. PMID: 30900410.
3. Steffen KJ, Kolotkin RL. A review of the combination of phentermine and topiramate extended-release for weight loss. Comb Prod Ther. 2012;2:3. doi:10.1007/s13556-012-0003-1.
4. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–1352. doi:10.1016/S0140-6736(11)60205-5. PMID: 21481449.
5. le Roux CW, Astrup A, Fujioka K, et al. The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy. eClinicalMedicine. 2022;49:101436. doi:10.1016/j.eclinm.2022.101436.
6. Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605. doi:10.1016/S0140-6736(10)60888-4. PMID: 20673995.
7. Naude J, Zentner A, Suresh P, et al. Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study. Int J Obes. 2024;48:1118–1125. doi:10.1038/s41366-024-01526-2.
8. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281(3):235–242. doi:10.1001/jama.281.3.235.
9. Van Gaal L, Dirinck E. Pharmacological approaches in the treatment and maintenance of weight loss. Diabetes Care. 2016;39(Suppl 2):S260–S267. doi:10.2337/dcS15-3016.
10. Gadde KM, Franciscy DM, Wagner HR, Krishnan KR. Topiramate for weight reduction in obese individuals: a randomized, double-blind, placebo-controlled trial. JAMA. 2003;289(14):1820–1825. doi:10.1001/jama.289.14.1820.
11. Wilding JPH, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M; OBES-002 Study Group. A randomized, double-blind, placebo-controlled study of the long-term efficacy and safety of topiramate in obese subjects. Int J Obes. 2004;28(11):1399–1410. doi:10.1038/sj.ijo.0802783.